References
- Barnes, T. A., O., Kane, G. M., Vincent, M. D., & Leighl, N. B. (2017). Third-generation tyrosine kinase inhibitors targeting epidermal growth factor receptor mutations in Non-Small Cell Lung Cancer. Frontiers in Oncology, 7, 113. https://doi.org/https://doi.org/10.3389/fonc.2017.00113
- Bayly, C. I., Cieplak, P., Cornell, W., & Kollman, P. A. (1993). A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: The RESP model. The Journal of Physical Chemistry, 97(40), 10269–10280. https://doi.org/https://doi.org/10.1021/j100142a004
- Becke, A. D. (1993). Density-functional thermochemistry III. The role of exact exchange. Journal of Chemical Physics, 98(7), 5648–5652. https://doi.org/https://doi.org/10.1063/1.464913
- Case, D., Darden, T., Cheatham, T., III, Simmerling, C., Wang, J., Duke, R., Luo, R., Walker, R., Zhang, W., Merz, K., Roberts, B., Hayik, S., Roitberg, A., Seabra, G., Swails, J., Goetz, A., Kolossváry, I., Wong, K., Paesani, F., … Kollman, P. (2012). AMBER 12. University of California.
- Cross, D. A. E., Ashton, S. E., Ghiorghiu, S., Eberlein, C., Nebhan, C. A., Spitzler, P. J., Orme, J. P., Finlay, M. R. V., Ward, R. A., Mellor, M. J., Hughes, G., Rahi, A., Jacobs, V. N., Brewer, M. R., Ichihara, E., Sun, J., Jin, H., Ballard, P., Al-Kadhimi, K., … Pao, W. (2014). AZD9291, an irreversible EGFR TKI, overcomes T790M-Mediated resistance to EGFR inhibitors in lung cancer. Cancer Discovery, 4(9), 1046–1061. https://doi.org/https://doi.org/10.1158/2159-8290.CD-14-0337
- Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N•log-(N) method for Ewald sums in large systems. Journal of Chemical Physics., 98(12), 10089–10092. https://doi.org/https://doi.org/10.1063/1.464397
- De Clercq, D., Heppner, D. E., To, C., Jang, J., Park, E., Yun, C. H., Mushajiang, M., Shin, B. H., Gero, T. W., Scott, D. A., Jänne, P. A., Eck, M. J., & Gray, N. S. (2019). Discovery and optimization of dibenzodiazepinones as allosteric mutant-selective EGFR Inhibitors. ACS Medicinal Chemistry Letters, 10(11), 1549–1553. https://doi.org/https://doi.org/10.1021/acsmedchemlett.9b00381
- Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Scalmani, G., Barone, V., Petersson, G. A., Nakatsuji, H., Li, X., Caricato, M., Marenich, A., Bloino, J., Janesko, B. G., Gomperts, R., Mennucci, B., Hratchian, H. P., Ortiz, J. V., … Fox, D. J. (2009). Gaussian 09. Gaussian, Inc.
- Fukui, K. (1982). Role of frontier orbitals in chemical reactions. Science (New York, N.Y.).), 218(4574), 747–754. https://doi.org/https://doi.org/10.1126/science.218.4574.747
- Giaccone, G., & Wang, Y. (2011). Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors. Cancer Treatment Reviews, 37(6), 456–464. https://doi.org/https://doi.org/10.1016/j.ctrv.2011.01.003
- Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., & Simmerling, C. (2006). Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins, 65(3), 712–725. https://doi.org/https://doi.org/10.1002/prot.21123
- Jia, Y., Yun, C., Park, E., Ercan, D., Manuia, M., Juarez, J., Xu, C., Rhee, K., Chen, T., Zhang, H., Palakurthi, S., Jang, J., Lelais, G., DiDonato, M., Bursulaya, B., Michellys, P., Epple, R., Marsilje, T. H., McNeill, M., … Eck, M. J. (2016). Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors. Nature, 534(7605), 129–132. https://doi.org/https://doi.org/10.1038/nature17960
- gensen, W., Chandrasekhar, J., & Madura, J. (1983). Comparison of simple potential functions for simulating liquid water. Journal of Chemical Physics, 79(2), 926–935.
- Kobayashi, S., Boggon, T. J., Dayaram, T., Jänne, P. A., Kocher, O., Meyerson, M., Johnson, B. E., Eck, M. J., Tenen, D. G., & Halmos, B. (2005). EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. The New England Journal of Medicine, 352(8), 786–792. https://doi.org/https://doi.org/10.1056/NEJMoa044238
- Onufriev, A., Bashford, D., & Case, D. A. (2004). Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins, 55(2), 383–394. https://doi.org/https://doi.org/10.1002/prot.20033
- Parr, R. G., & Pearson, R. G. (1983). Absolute hardness: Companion parameter to absolute electronegativity. Journal of the American Chemical Society, 105(26), 7512–7516. https://doi.org/https://doi.org/10.1021/ja00364a005
- Rocchia, W., Alexov, E., & Honig, B. (2001). Extending the applicability of the nonlinear Poisson − Boltzmann equation: Multiple dielectric constants and multivalent ions. The Journal of Physical Chemistry B, 105(28), 6507–6514. https://doi.org/https://doi.org/10.1021/jp010454y
- Ryckaert, J., Ciccotti, G., & Berendsen, H. (1977). Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. Journal of Computational Physics, 23(3), 327–341. https://doi.org/https://doi.org/10.1016/0021-9991(77)90098-5
- Sharma, S. V., Bell, D. W., Settleman, J., & Haber, D. A. (2007). Epidermal growth factor receptor mutations in lung cancer. Nature Reviews Cancer, 7(3), 169–181. https://doi.org/https://doi.org/10.1038/nrc2088
- Thress, K. S., Paweletz, C. P., Felip, E., Cho, B. C., Stetson, D., Dougherty, B., Lai, Z., Markovets, A., Vivancos, A., Kuang, Y., Ercan, D., Matthews, S. E., Cantarini, M., Barrett, J. C., Jänne, P. A., & Oxnard, G. R. (2015). Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M. Nature Medicine, 21(6), 560–562. https://doi.org/https://doi.org/10.1038/nm.3854
- Tian, Y., Zhang, T., Long, L., Li, Z., Wan, S., Wang, G., Yu, Y., Hou, J., Wu, X., & Zhang, J. (2018). Design, synthesis, biological evaluation and molecular modeling of novel 2-amino-4-(1-phenylethoxy) pyridine derivatives as potential ROS1 inhibitors. European Journal of Medicinal Chemistry, 143, 182–199. https://doi.org/https://doi.org/10.1016/j.ejmech.2017.11.002
- To, C., Jang, J., Chen, T., Park, E., Mushajiang, M., De Clercq, D., Xu, M., Wang, S., Cameron, M. D., Heppner, D. E., Shin, B. H., Gero, T. W., Yang, A., Dahlberg, S. E., Wong, K. K., Eck, M. J., Gray, N. S., & Jänne, P. A. (2019). Single and dual targeting of mutant EGFR with an allosteric inhibitor. Cancer Discovery, 9(7), 926–943. https://doi.org/https://doi.org/10.1158/2159-8290.CD-18-0903
- Torre, L. A., Siegel, R. L., & Jemal, A. (2016). Lung cancer statistics. Advances in Experimental Medicine and Biology, 893, 1–19. https://doi.org/https://doi.org/10.1007/978-3-319-24223-1_1
- Wan, S., Yan, R., Jiang, Y., Li, Z., Zhang, J., & Wu, X. (2019). Insight into binding mechanisms of EGFR allosteric inhibitors using molecular dynamics simulations and free energy calculations. Journal of Biomolecular Structure & Dynamics, 37(16), 4384–4394. https://doi.org/https://doi.org/10.1080/07391102.2018.1552197
- Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157–1174. https://doi.org/https://doi.org/10.1002/jcc.20035
- Wang, Y., Wan, S., Li, Z., Fu, Y., Wang, G., Zhang, J., & Wu, X. (2018). Design, synthesis, biological evaluation and molecular modeling of novel 1H -pyrazolo[3,4-d]pyrimidine derivatives as BRAF V600E and VEGFR-2 dual inhibitors. European Journal of Medicinal Chemistry, 155, 210–228. https://doi.org/https://doi.org/10.1016/j.ejmech.2018.05.054
- Yun, C. H., Mengwasser, K. E., Toms, A. V., Woo, M. S., Greulich, H., Wong, K. K., Meyerson, M., & Eck, M. J. (2008). The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proceedings of the National Academy of Sciences of the United States of America, 105(6), 2070–2075. https://doi.org/https://doi.org/10.1073/pnas.0709662105
- Zhao, P., Yao, M. Y., Zhu, S. J., Chen, J. Y., & Yun, C. H. (2018). Crystal structure of EGFR T790M/C797S/V948R in complex with EAI045. Biochemical and Biophysical Research Communications, 502(3), 332–337. https://doi.org/https://doi.org/10.1016/j.bbrc.2018.05.154